A Universal Bacteriophage T4 Nanoparticle Platform to Design Multiplex SARS-CoV-2 Vaccine Candidates by CRISPR Engineering.
Zhu J, Ananthaswamy N, Jain S, Batra H, Tang WC, Lewry DA, Richards ML, David SA, Kilgore PB, Sha J, Drelich A, Tseng CK, Chopra AK, Rao VB.
Zhu J, et al. Among authors: tang wc.
bioRxiv [Preprint]. 2021 Jan 20:2021.01.19.427310. doi: 10.1101/2021.01.19.427310.
bioRxiv. 2021.
PMID: 33501450
Free PMC article.
Updated.
Preprint.